Search results for: "Novo Nordisk"

(167 records)

Novo Nordisk focuses r&d on therapeutic proteins: job losses to be expected

Novo Nordisk is to focus all its r&d resources on the company\'s growing pipeline of protein-based pharmaceuticals. The company\'s r&d activities within small molecules for...

Novo Nordisk focuses r&d on therapeutic proteins: job losses to be expected

Novo Nordisk is to focus all its r&d resources on the company\'s growing pipeline of protein-based pharmaceuticals. The company\'s r&d activities within small molecules for...

EASD, JDRF and Novo Nordisk join forces in diabetes research

Novo Nordisk expands US diabetes field force

Novo Nordisk plans to expand its US diabetes care field force from 1,200 to approximately 1,900 people.

Novo Nordisk strengthens patent position within inhaled insulin

Healthcare group Novo Nordisk\'s has struck an agreement with California-based developer of drug delivery devices Aradigm Corp, which gives Aradigm a cash infusion of US$27.5m...

Innate Pharma and Novo Nordisk announce strategic partnership

French biopharmaceutical company Innate Pharma and Danish global healthcare company Novo Nordisk have entered into a major partnership to develop new drugs targeting natural...

Novo Nordisk opens the first haemostasis research facility in the US

Danish company Novo Nordisk has set up Novo Nordisk Research US, the first haemostasis research facility in the US dedicated to life-threatening bleeding....

Novo Nordisk receives subpoena in US

The US Attorney\'s office for the Eastern District of New York has served healthcare company Novo Nordisk with a subpoena calling for the production of documents relating to...

Novo Nordisk pushes on in EU and China

Novo Nordisk has been granted EU marketing authorisation by the European Medicines Agency (EMEA) for its new premix insulin analogues (biphasic insulin aspart), NovoMix 50 and...

Novo Nordisk strengthens drug research

Novo Nordisk expands Chinese production plant

Novo Nordisk expands Levemir production in Denmark

Novo Nordisk has broken ground for a new insulin purification facility in Kalundborg, Denmark.

Novo Nordisk expands production in China

Novo Nordisk is undertaking a significant expansion of its production facilities in Tianjin, China. Plans include a new assembly plant for Novo Nordisk\'s NovoPen 3 insulin pen...

Novo Nordisk expands production in the US

Novo Nordisk is planning a US$100m expansion of its insulin manufacturing plant in Clayton, North Carolina. The move will create around 200 new jobs, bringing the total to 600...

Novo Nordisk expands licensing rights to AERx iDMS

Danish company Novo Nordisk and US drug delivery specialist Aradigm Corporation have signed an agreement giving Novo Nordisk full development and manufacturing rights to the...

Transition Therapeutics licenses diabetes regenerative therapy to Novo Nordisk

Toronto-based biopharmaceutical company Transition Therapeutics has signed a licensing agreement with Novo Nordisk to develop Islet Neogenesis Therapy (INT) for the treatment...

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at Bausch and Lomb's Tampa manufacturing facility
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Japanese researchers report advances in liver disease treatment and cancer screening Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
  4. FDA approves Telix’s first FET-PET imaging drug for glioma Telix’s Pixclara is the first FDA-approved FET-PET imaging agent for glioma, enabling US clinicians to distinguish recurrent or progressive brain tumours from treatment-related changes
  5. Exceptional excipients enabled with expertise Growing regulatory expectations, increasing pressure to secure resilient regional supply chains and the need for more efficient manufacturing are reshaping how medicines are developed and produced

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing The platform supports pharmaceutical companies in developing, evaluating and optimising formulations and processes for continuous manufacturing
DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

Read more
Manufacturing Enzene is a CIDMO partner supporting innovators and biosimilar developers from discovery to commercial supply with integrated, paradigm-changing biologics services and...
Enzene: Bringing the most advanced innovations to biologics manufacturing

Enzene: Bringing the most advanced innovations to biologics manufacturing

Read more
Research & Development The collaboration combines human-relevant in vitro immunology with in vivo pharmacology to support biotech drug discovery programmes, including endometriosis research
Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Read more
Manufacturing UK CDMO Upperton can now manufacture sterile investigational medicinal products at its new 7,000 sq ft facility in Nottingham, expanding its GMP clinical supply capabilities
Upperton gains MHRA licence for Annex 1-aligned sterile facility

Upperton gains MHRA licence for Annex 1-aligned sterile facility

Read more
Pharma 5.0 The next phase of AI adoption in pharma could be less about discovering new medicines and more about tackling the operational barriers that prevent AI projects from scaling,...
Beyond drug discovery: the untapped value of AI in pharma operations

Beyond drug discovery: the untapped value of AI in pharma operations

Read more
Manufacturing As demand for HPAPIs and highly potent drug products grows, the pharmaceutical industry faces increasing pressure to combine containment, product and operator protection,...
Beyond containment: integrated line design reduces risk and complexity

Beyond containment: integrated line design reduces risk and complexity

Read more
Manufacturing Free in-person workshop combines expert theory with hands-on laboratory sessions to build confidence in viscosity measurement
Anton Paar’s popular viscosity workshop returns to Luton this October

Anton Paar’s popular viscosity workshop returns to Luton this October

Read more
Manufacturing New spray drying, dry granulation and pharmaceutical development solutions showcased at CPHI Milan
Glatt presents integrated particle engineering solutions at CPHI Milan

Glatt presents integrated particle engineering solutions at CPHI Milan

Read more